Welcome to nudaPETides. Coming soon.
The prescribing platform for veterinary peptide medicine. For licensed veterinarians.
Request accessA peptide is a short chain of amino acids. A tiny, naturally occurring messenger that tells the body to heal, repair, restore balance. Every mammal already relies on them. These monographs explain the peptides and blends in our launch formulary, and the real research behind peptide medicine for dogs and cats.
Compounded and shipped from a 503A pharmacy licensed for veterinary compounding, and prescribed by a licensed veterinarian for a specific patient.
Some peptides work better together. Our blends capture proven combinations so prescribing stays simple.
BPC-157 + TB-500
The two most trusted veterinary healing peptides in one vial.
Combines BPC-157 and TB-500 to reduce inflammation while enhancing regeneration, capturing both synergistic repair pathways in a single prescription.
Best for. Orthopedic, tendon, ligament, and muscle recovery. Built for working dogs, agility and sporting breeds, and seniors.
GHK-Cu + BPC-157 + TB-500
A triple-action regenerative blend.
Adds GHK-Cu to the Wolverine base for comprehensive tissue repair that addresses inflammation, wound healing, and structural remodeling together.
Best for. Skin, coat, and wound support alongside deeper tissue repair. Suited to dermatology, orthopedics, and longevity protocols.
Ta1, Thymalfasin
Immune modulation, not suppression.
A 28-amino-acid thymic peptide. The human form, thymalfasin, is approved in more than 35 countries.
Mechanism
Enhances T-cell mediated immunity, activates natural killer and dendritic cells, and modulates innate immune signaling. Balances rather than dampens the immune response.
Areas of veterinary interest
Prescribed within a valid VCPR and compounded by a licensed 503A pharmacy. Like all compounded medications, it is prepared under FDA enforcement discretion and is not an FDA-approved animal drug.
GRF 1-29, GHRH analog
Support for the growth hormone axis.
A growth hormone releasing hormone analog. It prompts the pituitary to produce the body's own growth hormone rather than replacing it.
Mechanism
Stimulates endogenous growth hormone release and downstream IGF-1 signaling while preserving the natural pulsatile rhythm.
Areas of veterinary interest
Prescribed within a valid VCPR and compounded by a licensed 503A pharmacy. Like all compounded medications, it is prepared under FDA enforcement discretion and is not an FDA-approved animal drug.
GSH, L-glutathione
The body's master antioxidant.
A tripeptide of glutamate, cysteine, and glycine, and the cell's primary antioxidant defense.
Mechanism
Neutralizes reactive oxygen species and supports hepatic detoxification pathways and cellular redox balance.
Areas of veterinary interest
Prescribed within a valid VCPR and compounded by a licensed 503A pharmacy. Like all compounded medications, it is prepared under FDA enforcement discretion and is not an FDA-approved animal drug.
Copper peptide GHK
Skin, coat, and tissue regeneration.
A copper-binding tripeptide naturally present in the body. A potent antioxidant and an established ingredient in dermatologic care.
Mechanism
Stimulates collagen and elastin synthesis, activates antioxidant enzymes, and supports wound closure and coat quality.
Areas of veterinary interest
Prescribed within a valid VCPR and compounded by a licensed 503A pharmacy. Like all compounded medications, it is prepared under FDA enforcement discretion and is not an FDA-approved animal drug.
Body Protection Compound 157
The premier tissue-repair peptide.
A 15-amino-acid peptide originally identified in gastric juice, with an excellent safety profile across mammals.
Mechanism
Supports angiogenesis, modulates the nitric oxide system, and promotes tendon, ligament, muscle, and gastrointestinal mucosal repair.
Areas of veterinary interest
Prescribed within a valid VCPR and compounded by a licensed 503A pharmacy. Like all compounded medications, it is prepared under FDA enforcement discretion and is not an FDA-approved animal drug.
Thymosin beta-4 fragment
Cellular repair and tissue remodeling.
A synthetic fragment of Thymosin beta-4. Well tolerated with a long track record in veterinary rehabilitation.
Mechanism
Promotes cell migration, angiogenesis, and tissue remodeling. Complements BPC-157 through synergistic repair pathways.
Areas of veterinary interest
Prescribed within a valid VCPR and compounded by a licensed 503A pharmacy. Like all compounded medications, it is prepared under FDA enforcement discretion and is not an FDA-approved animal drug.
GH secretagogue pairing
Growth hormone secretagogue support.
A selective growth hormone secretagogue paired with a GHRH analog for sustained, pulsatile release. An FDA-approved analog, capromorelin, is already in veterinary use.
Mechanism
Stimulates natural growth hormone secretion and IGF-1 elevation without disrupting the pulsatile pattern or appetite signaling.
Areas of veterinary interest
Prescribed within a valid VCPR and compounded by a licensed 503A pharmacy. Like all compounded medications, it is prepared under FDA enforcement discretion and is not an FDA-approved animal drug.
Lysine-Proline-Valine
A targeted anti-inflammatory tripeptide.
The C-terminal tripeptide of alpha-MSH, with a strong safety profile for longer-term use.
Mechanism
Inhibits the NF-kB and MAPK inflammatory pathways and is transported via PepT1 in the intestine. Reduces inflammation without immunosuppression.
Areas of veterinary interest
Prescribed within a valid VCPR and compounded by a licensed 503A pharmacy. Like all compounded medications, it is prepared under FDA enforcement discretion and is not an FDA-approved animal drug.
hGH fragment 177-191
A metabolic adjunct for body composition.
A fragment of growth hormone studied for fat metabolism. It carries GRAS status for food applications.
Mechanism
Stimulates lipolysis and inhibits lipogenesis without affecting blood glucose or IGF-1 levels.
Areas of veterinary interest
Prescribed within a valid VCPR and compounded by a licensed 503A pharmacy. Like all compounded medications, it is prepared under FDA enforcement discretion and is not an FDA-approved animal drug.
Nicotinamide adenine dinucleotide
Cellular energy and healthy aging.
A coenzyme central to cellular energy production and repair. Not a peptide, but a cornerstone of the longevity toolkit.
Mechanism
Fuels mitochondrial energy production and sirtuin activity, both of which decline with age.
Areas of veterinary interest
Prescribed within a valid VCPR and compounded by a licensed 503A pharmacy. Like all compounded medications, it is prepared under FDA enforcement discretion and is not an FDA-approved animal drug.
Short summaries of actual studies of peptides in dogs and cats. Educational, and cited. Some involve peptides beyond our formulary, included because they show how far the science has come.
A 2022 study in Frontiers in Pharmacology characterized the pharmacokinetics, distribution, metabolism, and excretion of BPC-157 in rats and beagle dogs. The researchers followed how the peptide is absorbed after dosing, where it travels in the body, and how quickly it clears.
Species-specific data like this is the foundation of responsible veterinary use. It is exactly what lets a veterinarian reason about dosing and timing in a dog rather than extrapolating blindly from other species. BPC-157 carries one of the deepest safety and mechanism literatures of any peptide in our formulary.
Source: Frontiers in Pharmacology, 2022
Read the studyIn a study published in Circulation: Heart Failure, dogs with advanced heart failure received chronic therapy with elamipretide, a mitochondria-targeting peptide. The researchers reported improvements in left ventricular function and in measures of mitochondrial function. A later 2019 study in ESC Heart Failure examined its effects on skeletal muscle in dogs with induced heart failure.
Elamipretide sits outside our launch formulary. We include it because it is a clear example of a peptide studied directly in dogs, at a serious clinical endpoint, that has also advanced into human cardiac trials. Peptide medicine for companion animals is being taken seriously by cardiologists, not just wellness circles.
Source: Circulation: Heart Failure, 2016
Read the studyCapromorelin is a peptide that activates the ghrelin receptor. It is FDA-approved as Entyce for stimulating appetite in dogs, and as Elura for managing weight loss in cats with chronic kidney disease. Published work has documented its ability to increase appetite and food intake in dogs.
This is the single most important point about the category. Peptide medicine for pets is not theoretical. A peptide therapy has already cleared the FDA's veterinary approval process for both dogs and cats and is prescribed in clinics today. The science is legitimate, and it is already here.
Source: US FDA approvals; J. Vet. Pharmacol. Ther., 2017
Read the studyFull protocols, weight-based dosing, and medical rationale templates live inside the platform. Available to approved veterinarians.